| IAa (n = 40) | EAb (n = 77) | p-value |
---|---|---|---|
Pain scale, NRSc | |||
 PODd 0 | 4.5 ± 2.0 | 4.0 ± 1.8 | 0.158 |
 PODd 1 | 3.6 ± 1.8 | 4.0 ± 1.8 | 0.301 |
 PODd 2 | 2.8 ± 1.3 | 2.9 ± 1.5 | 0.665 |
 PODd 3 | 2.2 ± 1.0 | 2.3 ± 1.0 | 0.659 |
Morphine (mg) | 10.6 ± 1.4 | 10.9 ± 1.6 | 0.906 |
Bowel movement (days) | |||
 Time to first flatus passage | 2.1 ± 1.1 | 2.5 ± 1.6 | 0.234 |
 Time to first stool passage | 3.7 ±2.3 | 4.6 ± 2.5 | 0.067 |
 Tolerate liquid diet | 2.9 ± 1.6 | 4.4 ± 3.0 | 0.006 |
 Tolerate soft diet | 4.6 ± 1.9 | 6.1 ± 3.1 | 0.007 |
Complications | 1 | 7 | 0.565 |
Early morbidity, n (%) | 0 (0) | 6 (7.8) | 0.07 |
Discharged morbidity, n (%) | 1 (2.5) | 1 (1.3) | 0.634 |
Clavien-Dindo classification | |||
 Grade 1 | 0 | 2 |  |
 Grade 2 | 1 | 3 |  |
 Grade 3 | 0 | 2 |  |
 Grade 4 | 0 | 0 |  |
 Grade 5 | 0 | 0 |  |
Mortality | 0 | 0 | Â |
Hospital stay (days) | 5.7 ± 1.9 | 7.7 ± 3.4 | 0.001 |
PODd 3 lab | |||
 WBCe (1000/uL) | 10.3 ± 3.8 | 10.7 ± 3.4 | 0.853 |
 Segment (%) | 79.2 ± 8.3 | 76.4 ± 7.1 | 0.077 |
 CRPf (mg/L) | 105 ± 70 | 70 ± 44 | 0.009 |